Oscar Krijgsman

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao et al. · Nature · 2020 · 2.7K citations · Full text

Life Sciences, Cell Biology, Immunology +16

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Christian U. Blank, Elisa A. Rozeman, Lorenzo F. Fanchi et al. · Nature Medicine · 2018 · 855 citations

Medicine, Immunology, Oncology +14

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Judith M. Müller, Oscar Krijgsman, Jennifer Tsoi et al. · Nature Communications · 2014 · 637 citations · Full text

Medicine, Oncology, Pharmacology +16

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi et al. · The Lancet Oncology · 2019 · 522 citations

Pharmacy, Oncology, Pharmacokinetics +16

Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

Fleur Weeber, Marc van de Wetering, Marlous Hoogstraat et al. · Proceedings of the National Academy of Sciences · 2015 · 487 citations · Full text

Medicine, Cancer Biology, Oncology +17